Biosafety and Bioethics MCQs (Set-3)

Difficulty: Medium

Assess a proposed study with a biological agent. Which risk-assessment approach is strongest?

A skip assessment for familiar materials
B choose controls based only on cost
C assign containment solely from the agent name
D consider the agent and the specific procedures, exposure routes, scale, and controls

A hazard has severe potential consequences but a low estimated likelihood under current controls. What is the best interpretation?

A risk still requires evaluation of both likelihood and consequence, including residual uncertainty
B controls make reassessment unnecessary
C risk is zero because likelihood is low
D severity alone proves an incident will occur

A new procedure increases sample concentration and adds an aerosol-generating step. What should happen before implementation?

A review and update the risk assessment and controls
B reuse the old assessment without review
C remove PPE to improve handling
D change only the sample label

In the hierarchy of risk controls, which measure is generally more reliable than relying only on PPE?

A voluntary self-reporting only
B a verbal warning after every task
C a reminder poster alone
D engineering containment such as a suitable biological safety cabinet

A biological safety cabinet has been moved to a new location. What should be checked before use?

A certification and performance after relocation
B the number of posters nearby
C whether all staff have the same gloves
D the sample accession number

A lab compares two disinfectants for a spill. Which evidence should guide selection?

A the bottle color only
B the fragrance of the product
C which one was purchased first
D the agent or material, product efficacy, surface, contact time, and local procedure

A lab uses a biological safety cabinet for work with a volatile toxic chemical. What is the concern?

A PPE is never needed
B the chemical becomes nonvolatile in a cabinet
C the cabinet guarantees protection from every vapor
D a biological cabinet may not be designed to control chemical vapors safely

An environmental assessment finds a modified plant can cross with a compatible wild relative. Which risk pathway should be evaluated?

A the laboratory’s autoclave cycle
B gene flow and its possible ecological consequences
C only the plant’s height
D the sequence file format

A modified microbe is intended for contained use but could survive outside the facility. Which control strategy is relevant?

A rely on a warning sign alone
B assume the organism will die immediately
C combine appropriate physical containment with validated biological safeguards and monitoring
D remove inventory records

A biosafety assessment identifies a control that reduces exposure but leaves some residual risk. What should the team do?

A evaluate whether residual risk is acceptable and add controls if needed
B ignore the remaining risk
C stop documenting controls
D declare zero risk automatically

An ethics committee asks whether participants understand a genomic study’s future data sharing. Which evidence is most useful?

A a signed form alone with no discussion
B a consent process that explains sharing in understandable language and checks comprehension
C a sequence alignment report
D a laboratory certificate

A research participant asks to withdraw but the sample has already contributed to aggregated results. What response is most appropriate?

A tell the participant they can never withdraw
B promise to erase every derived result regardless of feasibility
C explain the options and limits described in consent and policy, without promising impossible deletion
D publish the sample identifier

A study stores genome data without direct identifiers but retains detailed metadata that could identify a person. What remains necessary?

A removal of all metadata regardless of research purpose
B privacy and re-identification risk controls
C no access controls because names are absent
D public release of the linkage key

A participant’s genomic data may reveal information about biological relatives. Which issue should be addressed?

A whether the lab has an autoclave
B familial implications and privacy in consent and data governance
C only the participant’s blood type
D the sequence file’s font

A study recruits from a disadvantaged population because access is easy, while benefits will only be available to wealthy groups. Which ethical concern is raised?

A unfair distribution of burdens and benefits
B proper anonymization
C sequence coverage
D sample contamination

A community contributes samples and local knowledge to a genomic project. Which practice supports ethical partnership?

A engage the community and discuss governance and fair sharing of benefits
B publish identifiable community data
C assume individual consent covers every community issue
D collect materials without communication

A study uses human genome data from an earlier project. What must be checked before reuse?

A only sequence length
B whether the first study was published
C original consent scope, ethics approval, privacy safeguards, and applicable rules
D whether the data are in FASTA format

A gene-editing study proposes a heritable change in embryos. What distinction is central to ethical analysis?

A germline edits can never affect descendants
B both changes affect only the treated tissue
C somatic editing always changes offspring
D germline changes may be passed to future generations, unlike targeted somatic changes

A researcher finds an unexpected health-related result in a participant’s genome. Which factor should guide disclosure?

A whether the participant’s name is known
B the consent plan, result validity, clinical relevance, and appropriate support
C whether the result is publishable
D the researcher’s curiosity alone

A study team has no agreed policy for returning individual genetic results. What should happen before enrollment?

A leave decisions to whichever analyst is on duty
B promise every raw result will be returned immediately
C develop and communicate a clear return-of-results policy
D avoid mentioning results in consent

A lab discovers that a researcher has fabricated a control result. What is the appropriate response?

A alter the dataset to match the hypothesis
B delete the notebook
C preserve records and report through the institution’s research-integrity process
D wait until publication

Two collaborators disagree on authorship after the work is complete. Which practice would have helped most?

A list everyone who visited the lab
B agree on contributions and authorship criteria early and document changes
C omit the methods section
D assign authorship by seniority alone

A project has a potential dual-use concern but also a legitimate public-health goal. What is the balanced response?

A cancel all beneficial research automatically
B ignore the concern because intent is good
C assess benefits and misuse risks, then apply proportionate safeguards and oversight
D publish all details without review

A laboratory biosecurity plan protects sensitive materials and records. Which measure is relevant?

A unlabeled storage
B open access for any visitor
C shared passwords
D controlled access, inventory accountability, and secure data handling

A risk assessment identifies a spill route through a centrifuge. Which change best addresses the source of exposure?

A remove the incident log
B ask staff to work faster
C add a poster but keep the same setup
D use suitable containment and equipment controls for the procedure